News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
652,701 Results
Type
Article (53758)
Company Profile (226)
Press Release (598717)
Multimedia
Podcasts (94)
Webinars (17)
Section
Business (179374)
Career Advice (2846)
Deals (32503)
Drug Delivery (117)
Drug Development (80403)
Employer Resources (168)
FDA (15431)
Job Trends (14287)
News (315239)
Policy (31228)
Tag
Academia (2805)
Academic (1)
Accelerated approval (9)
Adcomms (32)
Allergies (103)
Alliances (49703)
ALS (116)
Alzheimer's disease (1509)
Antibody-drug conjugate (ADC) (178)
Approvals (15402)
Artificial intelligence (341)
Autoimmune disease (35)
Automation (18)
Bankruptcy (348)
Best Places to Work (11215)
BIOSECURE Act (21)
Biosimilars (128)
Biotechnology (175)
Bladder cancer (97)
Brain cancer (38)
Breast cancer (371)
Cancer (2960)
Cardiovascular disease (233)
Career advice (2388)
Career pathing (33)
CAR-T (198)
CDC (35)
Cell therapy (536)
Cervical cancer (22)
Clinical research (66110)
Collaboration (1077)
Company closure (3)
Compensation (475)
Complete response letters (27)
COVID-19 (2737)
CRISPR (64)
C-suite (346)
Cystic fibrosis (112)
Data (3010)
Decentralized trials (2)
Denatured (24)
Depression (71)
Diabetes (365)
Diagnostics (6340)
Digital health (22)
Diversity (8)
Diversity, equity & inclusion (43)
Drug discovery (145)
Drug pricing (140)
Drug shortages (30)
Duchenne muscular dystrophy (127)
Earnings (63360)
Editorial (46)
Employer branding (22)
Employer resources (151)
Events (94218)
Executive appointments (886)
FDA (17068)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (951)
Gene editing (139)
Generative AI (28)
Gene therapy (419)
GLP-1 (860)
Government (4644)
Grass and pollen (6)
Guidances (178)
Healthcare (18088)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (177)
Immuno-oncology (10)
Indications (39)
Infectious disease (2925)
Inflammatory bowel disease (154)
Inflation Reduction Act (13)
Influenza (67)
Intellectual property (122)
Interviews (563)
IPO (14638)
IRA (53)
Job creations (3438)
Job search strategy (1973)
Kidney cancer (15)
Labor market (43)
Layoffs (521)
Leadership (25)
Legal (7068)
Liver cancer (84)
Lung cancer (422)
Lymphoma (208)
Machine learning (11)
Management (59)
Manufacturing (399)
MASH (99)
Medical device (12190)
Medtech (12194)
Mergers & acquisitions (18559)
Metabolic disorders (910)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (136)
Neuropsychiatric disorders (38)
Neuroscience (2233)
NextGen: Class of 2025 (6477)
Non-profit (4502)
Now hiring (43)
Obesity (459)
Opinion (273)
Ovarian cancer (100)
Pain (117)
Pancreatic cancer (123)
Parkinson's disease (193)
Partnered (22)
Patents (303)
Patient recruitment (165)
Peanut (54)
People (56814)
Pharmaceutical (43)
Pharmacy benefit managers (19)
Phase I (20597)
Phase II (29079)
Phase III (21815)
Pipeline (1648)
Policy (224)
Postmarket research (2588)
Preclinical (8605)
Press Release (70)
Prostate cancer (142)
Psychedelics (43)
Radiopharmaceuticals (260)
Rare diseases (498)
Real estate (5557)
Recruiting (71)
Regulatory (22093)
Reports (36)
Research institute (2428)
Resumes & cover letters (435)
Rett syndrome (10)
RNA editing (9)
RSV (53)
Schizophrenia (95)
Series A (166)
Series B (114)
Service/supplier (12)
Sickle cell disease (65)
Special edition (21)
Spinal muscular atrophy (159)
Sponsored (36)
Startups (3550)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (59)
The Weekly (69)
Vaccines (838)
Venture capital (56)
Weight loss (295)
Women's health (39)
Worklife (19)
Date
Last 7 days (365)
Last 30 days (1763)
Last 365 days (30474)
2025 (16339)
2024 (34163)
2023 (38366)
2022 (49304)
2021 (53300)
2020 (51868)
2019 (45321)
2018 (34483)
2017 (31682)
2016 (30469)
2015 (35206)
2014 (28766)
2013 (24773)
2012 (24679)
2011 (25457)
2010 (23243)
Location
Africa (905)
Alabama (62)
Alaska (6)
Arizona (188)
Arkansas (13)
Asia (40039)
Australia (7749)
California (6983)
Canada (2246)
China (689)
Colorado (300)
Connecticut (307)
Delaware (189)
Europe (91096)
Florida (1093)
Georgia (224)
Hawaii (1)
Idaho (57)
Illinois (618)
India (28)
Indiana (354)
Iowa (16)
Japan (231)
Kansas (109)
Kentucky (26)
Louisiana (14)
Maine (61)
Maryland (994)
Massachusetts (5098)
Michigan (235)
Minnesota (417)
Mississippi (3)
Missouri (85)
Montana (25)
Nebraska (26)
Nevada (80)
New Hampshire (68)
New Jersey (1992)
New Mexico (30)
New York (2007)
North Carolina (1053)
North Dakota (9)
Northern California (3042)
Ohio (221)
Oklahoma (14)
Oregon (33)
Pennsylvania (1455)
Puerto Rico (17)
Rhode Island (33)
South America (1215)
South Carolina (33)
South Dakota (1)
Southern California (2648)
Tennessee (114)
Texas (1062)
United States (25963)
Utah (206)
Virginia (184)
Washington D.C. (66)
Washington State (623)
West Virginia (4)
Wisconsin (63)
652,701 Results for "kuros biosciences formally known as cytos biotech merged with kuros biosurgery".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich
May 13, 2025
·
5 min read
Press Releases
Kuros Biosciences grows sales to CHF 75.6 million for 2024
March 11, 2025
·
10 min read
Press Releases
Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025
April 15, 2025
·
7 min read
Annual General Meeting of Kuros Biosciences Approves All Resolutions
Kuros Biosciences (SIX:KURN), a leader in next generation bone graft technologies, held its Annual General Meeting today.
April 17, 2024
·
2 min read
Press Releases
Kuros Biosciences Expands into Extremities Markets
November 19, 2024
·
5 min read
Press Releases
Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division
January 7, 2025
·
4 min read
Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages
Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that MagnetOs Flex Matrix has been cleared for use in the interbody space by the U.S. Food and Drug Administration (FDA).
November 28, 2023
·
5 min read
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
Kuros Biosciences, a leader in next generation bone graft technologies, announced it will present at the CG 2024 Musculoskeletal Conference, to be held in San Francisco on February 12, 2024.
February 1, 2024
·
3 min read
Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales
Kuros Biosciences, a leader in advanced bone healing technologies, announced its financial performance for the first quarter of 2024.
April 24, 2024
·
6 min read
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Kuros Biosciences, a leader in next generation bone healing technologies, announced the publication of a peer-reviewed manuscript that details the clinical data of its MAXA Level 1 prospective, multi-center, randomized, intra-patient controlled clinical study in Spine 1.
June 25, 2024
·
6 min read
1 of 65,271
Next
